677
Views
23
CrossRef citations to date
0
Altmetric
Original

Hemoglobin-Vesicles as a Transfusion Alternative

, , &
Pages 581-588 | Published online: 11 Jul 2009

REFERENCES

  • Kobayashi, K., Tsuchida, E., Horinouchi, H. (2005). Artificial Oxygen Carriers, Its Front Line, Springer-Verlag: Tokyo.
  • Chang, T.M.S. (2005). Therapeutic applications of polymeric artificial cells. Nat. Rev. Drug Discov. 4: 221–235. [INFOTRIEVE], [CSA]
  • Sakai, H., Tomiyama, K., Sou, K., Takeoka, S., Tsuchida, E. (2000). Poly(ethyleneglycol)-conjugation and deoxygenation enable long term preservation of hemoglobin vesicles as oxygen carriers. Bioconjugate Chem. 11: 425–432. [CSA], [CROSSREF]
  • Djordjevich, L., Mayoral, J., Miller, I.F., Ivankovich, A.D. (1987). Cardiorespiratory effects of exchanginge transfusions with synthetic erythrocytes in rats. Crit. Care. Med. 15: 318–323. [INFOTRIEVE], [CSA]
  • Izumi, Y., Sakai, H., Hamada, K., Takeoka, S., Yamahata, T., Kato, R., Nishide, H., Tsuchida, E., Kobayashi, K. (1996). Physiologic responses to exchange transfusion with hemoglobin vesicles as an artificial oxygen carrier in anesthetized rats: changes in mean arterial pressure and renal cortical tissue oxygen tension. Crit. Care. Med. 24: 1869–1873. [INFOTRIEVE], [CSA], [CROSSREF]
  • Rudolph, A.S., Klipper, R.W., Goins, B., Phillips, W.T. (1991). In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. Proc. Natl. Acad. Sci. USA 88: 10976–10980. [INFOTRIEVE], [CSA], [CROSSREF]
  • Ito, T., Fujihara, M., Abe, H., Yamaguchi, M., Wakamoto, S., Takeoka, S., Sakai, H., Tsuchida, E., Ikeda, H., Ikebuchi, K. (2001). Effects of poly(ethyleneglycol)-modified hemoglobin vesicles on N-formyl-methionyl-leucyl-phenylalanine-induced responses of polymorphonuclear neutrophils in vitro. Artif. Cells Blood Substit. Immobil. Biotechnol. 29: 427–437. [INFOTRIEVE], [CSA], [CROSSREF]
  • Wakamoto, S., Fujihara, M., Abe, H., Yamaguchi, M., Azuma, H., Ikeda, H., Takeoka, S., Tsuchida E. (2005). Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro. Artif. Cells Blood Substit. Immobil. Biotechnol. 33: 101–111. [INFOTRIEVE], [CSA]
  • Izumi, Y., Sakai, H., Kose, T., Hamada, K., Takeoka, S., Yoshizu, A., Horinouchi, H., Kato, R., Nishide, H., Tsuchida, E., Kobayashi, K. (1997). Evaluation of the capabilities of a hemoglobin vesicle as an artificial oxygen carrier in a rat exchange transfusion model. ASAIO J. 43: 289–297. [INFOTRIEVE], [CSA], [CROSSREF]
  • Kobayashi, K., Izumi, Y., Yoshizu, A., Horinouchi, H., Park, S.I., Sakai, H., Takeoka, S., Nishide, H., Tsuchida, E. (1997). The oxygen carrying capability of hemoglobin vesicles evaluated in rat exchange transfusion models. Artif. Cells Blood Substit. Immobil. Biotechnol. 25: 357–366. [INFOTRIEVE], [CSA]
  • Sakai, H., Takeoka, S., Park, S.I., Kose, T., Nishide, H., Izumi, Y., Yoshizu, A., Kobayashi, K., Tsuchida, E. (1997). Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats. Bioconjugate Chem. 8: 23–30. [CSA], [CROSSREF]
  • Sakai, H., Horinouchi, H., Yamamoto, M., Ikeda, E., Takeoka, S., Takaori, M., Tsuchida, E., Kobayashi, K. (2006). Acute 40% exchange transfusion with Hb-vesicles (HbV) suspended in recombinant HSA solution: Degradation of HbV and erythropoiesis in rat spleen observed for 2 weeks. Transfusion 46: 339–347. [INFOTRIEVE], [CSA], [CROSSREF]
  • Sakai, H., Masada, Y., Horinouchi, H., Yamamoto, M., Ikeda, E., Takeoka, S., Kobayashi, K., Tsuchida, E. (2004). Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit. Care Med. 32: 539–545. [INFOTRIEVE], [CSA], [CROSSREF]
  • Yoshizu, A., Izumi, Y., Park, S., Sakai, H., Takeoka, S., Horinouchi, H., Ikeda, E., Tsuchida, E., Kobayashi, K. (2004). Hemorrhagic shock resuscitation with an artificial oxygen carrier Hemoglobin Vesicle (HbV) maintains intestinal perfusion and suppresses the increase in plasma TNFα. ASAIO J. 50: 458–463. [INFOTRIEVE], [CSA], [CROSSREF]
  • Sakai, H., Cabrales, P., Tsai, A.G., Tsuchida, E., Intaglietta, M. (2005). Oxygen release from low and normal P50 Hb vesicles in transiently occluded arterioles of the hamster window model. Am. J. Physiol. Heart Circ. Physiol. 288: H2897–H2903. [INFOTRIEVE], [CSA], [CROSSREF]
  • Cabrales, P., Sakai, H., Tsai, A.G., Takeoka, S., Tsuchida, E., Intaglietta, M. (2005). Oxygen transport by low and normal oxygen affinity hemoglobin vesicles in extreme hemodilution. Am. J. Physiol. Heart Circ. Physiol. 288: H1885–H1892. [INFOTRIEVE], [CSA], [CROSSREF]
  • Contaldo, C., Plock, J., Sakai, H., Takeoka, S., Tsuchida, E., Leunig, M., Banic, A., Erni, D. (2005). New generation of hemoglobin-based oxygen carriers evaluated for oxygenation of critically ischemic hamster flap tissue. Crit. Care Med. 33: 806–812. [INFOTRIEVE], [CSA], [CROSSREF]
  • Plock, J.A., Contaldo, C., Sakai, H., Tsuchida, E., Leunig, M., Banic, A., Menger, M.D., Erni, D. (2005). Is Hb in Hb vesicles infused for isovolemic hemodilution necessary to improve oxygenation in critically ischemic hamster skin? Am. J. Physiol. Heart Circ. Physiol. 289: 12624–12631. [CSA], [CROSSREF]
  • Sakai, H., Hara, H., Yuasa, M., Tsai, A.G., Takeoka, S., Tsuchida, E., Intaglietta, M. (2000). Molecular dimensions of Hb-based O2 carriers determine constriction of resistance arteries and hypertension in conscious hamster model. Am. J. Physiol. Heart Circ. Physiol. 279: H908–H915. [INFOTRIEVE], [CSA]
  • Goda, N., Suzuki, K., Naito, M., Takeoka, S., Tsuchida, E., Ishimura, Y., Tamatani, T., Suematsu, M. (1998). Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation. J. Clin. Invest. 101: 604–612. [INFOTRIEVE], [CSA]
  • Sou, K., Klipper, R., Goins, B., Tsuchida, E., Phillips, W.T. (2005). Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute. J. Pharmacol. Exp. Ther. 312: 702–709. [INFOTRIEVE], [CSA], [CROSSREF]
  • Sakai, H., Horinouchi, H., Tomiyama, K., Iikeda, E., Takeoka, S., Kobayashi, K., Tsuchida, E. (2001). Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in metabolism. Am. J. Pathol. 159: 1079–1088. [INFOTRIEVE], [CSA]
  • Sakai, H., Tomiyama, K., Masada, Y., Takeoka, S., Horinouchi, H., Kobayashi, K., Tsuchida, E. (2003). Pretreatment of serum containing hemoglobin vesicles (oxygen carriers) to prevent their interference in laboratory tests. Clin. Chem. Lab. Med. 41: 222–231. [INFOTRIEVE], [CSA], [CROSSREF]
  • Sakai, H., Horinouchi, H., Masada, Y., Takeoka, S., Kobayashi, K., Tsuchida, E. (2004). Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model. Biomaterials 25: 4371–4325. [CSA], [CROSSREF]
  • Sakai, H., Masada, Y., Horinouchi, H., Ikeda, E., Sou, K., Takeoka, S., Suematsu, M., Kobayashi, K., Tsuchida, E. (2004). Physiologic capacity of reticuloendothelial system for degradation of hemoglobin-vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days. J. Pharmacol. Exp. Ther. 311: 874–884. [INFOTRIEVE], [CSA], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.